Cargando…
Infliximab rescue therapy in a patient with acute severe ulcerative colitis and coronavirus disease 2019 followed by Escherichia coli 0157:H7 infection: a case report
The management of patients with acute severe ulcerative colitis and SARS-CoV-2 presents a clinical challenge. We report on the first case of a patient with acute severe ulcerative colitis and mild coronavirus disease 2019 (COVID-19) who received rescue infliximab therapy, followed by a relapse cause...
Autores principales: | Bekić, Dinko, Belošić Halle, Željka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Croatian Medical Schools
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771238/ https://www.ncbi.nlm.nih.gov/pubmed/34981697 http://dx.doi.org/10.3325/cmj.2021.62.634 |
Ejemplares similares
-
Isolation of Escherichia coli 0157:H7 Strain from Fecal Samples of Zoo Animal
por: Mohammed Hamzah, Aseel, et al.
Publicado: (2013) -
Synthesis, characterization and immunological properties of Escherichia coli 0157:H7 lipopolysaccharide- diphtheria toxoid conjugate vaccine
por: Rokhsartalab-Azar, Shadi, et al.
Publicado: (2015) -
Infliximab in ulcerative colitis
por: Levin, Avi, et al.
Publicado: (2008) -
Temporal Variation of Faecal Shedding of Escherichia coli 0157:H7 in A Dairy Herd Producing Raw Milk for Direct Human Consumption
por: Merialdi, Giuseppe, et al.
Publicado: (2014) -
Infliximab Rescue in Acute Severe Ulcerative Colitis Complicated by Clostridium Difficile Infection: A Case Series
por: Markovic, Srdjan, et al.
Publicado: (2021)